Table 1.
Summary of clinical characteristics of study participants.
| n (%) | ||
|---|---|---|
| Age at surgery (n = 83) | <51 | 16 (19.28) |
| 51–61 | 23 (27.71) | |
| 62–70 | 22 (26.51) | |
| >70 | 22 (26.51) | |
| Gender (n = 83) | Male | 63 (75.90) |
| Female | 20 (24.10) | |
| Histology (n = 83) | pRCC type 1 | 20 (24.10) |
| pRCC type 2 | 44 (53.00) | |
| CDC | 14 (16.90) | |
| HGUC | 5 (6.00) | |
| Clinical stage (n = 83) | I | 32 (38.60) |
| II | 7 (8.40) | |
| III | 21 (25.30) | |
| IV | 23 (27.70) | |
| Tumor size, cm (n = 83) | <4 | 16 (19.50) |
| 4–7 | 31 (37.80) | |
| >7 | 35 (42.70) | |
| Metastasis at diagnosis (n = 83) | Yes | 20 (24.10) |
| No | 63 (75.90) | |